CCM
BSX icon

Conway Capital Management’s Boston Scientific BSX Stock Holding History

Conway Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
28,750
-150
-0.5% -$8.14K 0.55% 25
2026
Q1 		$1.81M Sell
28,900
-495
-2% -$39.6K 0.85% 18
2025
Q4 		$2.8M Sell
29,395
-250
-0.8% -$24.5K 1.19% 14
2025
Q3 		$2.89M Hold
29,645
– – 1.21% 15
2025
Q2 		$3.18M Sell
29,645
-1,725
-5% -$175K 1.42% 15
2025
Q1 		$3.16M Sell
31,370
-555
-2% -$55.9K 1.58% 15
2024
Q4 		$2.85M Hold
31,925
– – 1.26% 16
2024
Q3 		$2.68M Hold
31,925
– – 1.3% 17
2024
Q2 		$2.46M Hold
31,925
– – 1.24% 15
2024
Q1 		$2.19M Hold
31,925
– – 1.22% 15
2023
Q4 		$1.85M Sell
31,925
-2,090
-6% -$112K 1.19% 16
2023
Q3 		$1.8M Sell
34,015
-3,375
-9% -$177K 1.31% 15
2023
Q2 		$2.02M Sell
37,390
-2,550
-6% -$133K 1.42% 14
2023
Q1 		$2M Sell
39,940
-2,650
-6% -$125K 1.64% 14
2022
Q4 		$1.97M Buy
42,590
+7,250
+21% +$314K 1.99% 13
2022
Q3 		$1.37M Sell
35,340
-135
-0.4% -$5.42K 1.22% 17
2022
Q2 		$1.32M Sell
35,475
-550
-2% -$22.4K 1.18% 19
2022
Q1 		$1.6M Buy
36,025
+4,875
+16% +$211K 1.02% 18
2021
Q4 		$1.32M Buy
31,150
+2,000
+7% +$84K 0.78% 23
2021
Q3 		$1.26M Hold
29,150
– – 0.86% 24
2021
Q2 		$1.25M Hold
29,150
– – 0.85% 24
2021
Q1 		$1.13M Sell
29,150
-1,800
-6% -$68.1K 0.84% 25
2020
Q4 		$1.11M Buy
+30,950
New +$1.12M 0.81% 25

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Conway Capital Management's BSX Position: Q2 2026 in Review

Conway Capital Management reduced its Boston Scientific (BSX) stake by 0.52% in Q2 2026, selling an estimated $8.14K and leaving 28,750 shares worth $1.23M. The position accounts for 0.55% of the portfolio, ranked #25.

Conway Capital Management first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.18M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Conway Capital Management held 28,750 shares of Boston Scientific worth $1.23M as of Q2 2026.
  • Conway Capital Management sold 150 Boston Scientific shares in Q2 2026, an estimated $8.14K.
  • Boston Scientific made up 0.55% of Conway Capital Management's portfolio in Q2 2026, its #25 holding.
  • Conway Capital Management first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • Conway Capital Management's Boston Scientific position peaked at $3.18M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Conway Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.